Donatella Ruggiero

Monza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

" Real-world procedural outcomes on adoption of a novel stylet-driven, fixed-helix lead for left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING)".

" Real-world procedural outcomes on adoption of a novel stylet-driven, fixed-helix lead for left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING)".

Journal: Heart rhythm

Published: May 24, 2026

Impact of Left Bundle Branch Area Pacing on Echocardiographic Parameters and Symptoms: Data From the Conduction System Pacing Italian Network Group (C-SING) Study.

Impact of Left Bundle Branch Area Pacing on Echocardiographic Parameters and Symptoms: Data From the Conduction System Pacing Italian Network Group (C-SING) Study.

Journal: Journal of cardiovascular electrophysiology

Published: February 03, 2026

Selective Use of Nonselective Beta-Blockers: A Tailored Antiarrhythmic Approach.

Selective Use of Nonselective Beta-Blockers: A Tailored Antiarrhythmic Approach.

Journal: JACC. Clinical electrophysiology

Published: January 28, 2026

Spontaneous coronary artery dissection and sudden cardiac arrest: a reversible event or an indication for secondary prevention?

Spontaneous coronary artery dissection and sudden cardiac arrest: a reversible event or an indication for secondary prevention?

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: December 31, 2025

Flecainide in structural heart diseases: A contemporary reappraisal beyond the CAST.

Flecainide in structural heart diseases: A contemporary reappraisal beyond the CAST.

Journal: Heart rhythm

Published: July 21, 2025

A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use.

A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use.

Journal: Scientific reports

Published: March 31, 2025

New-Onset Device-Detected Atrial Fibrillation in Patients With Atrial Floating Dipole Implantable Cardioverter-Defibrillators: A Propensity Score-Matched Comparison With Conventional Dual-Chamber Systems.

New-Onset Device-Detected Atrial Fibrillation in Patients With Atrial Floating Dipole Implantable Cardioverter-Defibrillators: A Propensity Score-Matched Comparison With Conventional Dual-Chamber Systems.

Journal: Journal of cardiovascular electrophysiology

Published: January 31, 2025

Real-world adoption of left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING).

Real-world adoption of left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING).

Journal: International journal of cardiology

Published: September 10, 2024

Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database.

Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database.

Journal: Pharmacological reports : PR

Published: June 17, 2024

Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System.

Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System.

Journal: Therapeutic advances in drug safety

Published: June 12, 2024

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database.

Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database.

Journal: Drugs - real world outcomes

Published: October 10, 2023

Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis.

Journal: Frontiers in pharmacology

Published: June 26, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026